Literature DB >> 21306837

A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users.

Karen S Ingersoll1, Leah Farrell-Carnahan, Jessye Cohen-Filipic, Carolyn J Heckman, Sherry D Ceperich, Jennifer Hettema, Gabrielle Marzani-Nissen.   

Abstract

BACKGROUND: Crack cocaine use undermines adherence to highly active antiretroviral therapy (HAART). This pilot randomized clinical trial tested the feasibility and efficacy of 2 interventions based on the Information-Motivation-Behavioral Skill model to improve HAART adherence and reduce crack cocaine problems.
METHODS: Participants were 54 adults with crack cocaine use and HIV with <90% HAART adherence. Most participants were African-American (82%) heterosexual (59%), and crack cocaine dependent (92%). Average adherence was 58% in the past 2 weeks. Average viral loads (VL) were detectable (logVL 2.97). The interventions included 6 sessions of Motivational Interviewing plus feedback and skills building (MI+), or Video information plus debriefing (Video+) over 8 weeks. Primary outcomes were adherence by 14-day timeline follow-back and Addiction Severity Index (ASI) Drug Composite Scores at 3 and 6 months. Repeated measure ANOVA assessed main effects of the interventions and interactions by condition.
RESULTS: Significant increases in adherence and reductions in ASI Drug Composite Scores occurred in both conditions by 3 months and were maintained at 6 months, representing medium effect sizes. No between group differences were observed. No VL changes were observed in either group. Treatment credibility, retention, and satisfaction were high and not different by condition.
CONCLUSIONS: A counseling and a video intervention both improved adherence and drug problems durably among people with crack cocaine use and poor adherence in this pilot study. The interventions should be tested further among drug users with poor adherence. Video interventions may be feasible and scalable for people with HIV and drug use.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21306837      PMCID: PMC3102141          DOI: 10.1016/j.drugalcdep.2010.12.016

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  43 in total

1.  Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.

Authors:  J H Arnsten; P A Demas; H Farzadegan; R W Grant; M N Gourevitch; C J Chang; D Buono; H Eckholdt; A A Howard; E E Schoenbaum
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

Review 2.  Patient adherence to HIV medication regimens: a review of published and abstract reports.

Authors:  Linda Fogarty; Debra Roter; Susan Larson; Jessica Burke; Jeanne Gillespie; Richard Levy
Journal:  Patient Educ Couns       Date:  2002-02

3.  Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women.

Authors:  Tanya Telfair Sharpe; Lisa M Lee; Allyn K Nakashima; Laurie D Elam-Evans; Patricia L Fleming
Journal:  J Community Health       Date:  2004-04

Review 4.  Clinical management of HIV-1 resistance.

Authors:  Roger Paredes; Bonaventura Clotet
Journal:  Antiviral Res       Date:  2009-10-04       Impact factor: 5.970

5.  New data from the Addiction Severity Index. Reliability and validity in three centers.

Authors:  A T McLellan; L Luborsky; J Cacciola; J Griffith; F Evans; H L Barr; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1985-07       Impact factor: 2.254

6.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

7.  Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.

Authors:  Gregory M Lucas; Kelly A Gebo; Richard E Chaisson; Richard D Moore
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

8.  Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.

Authors:  Cunlin Wang; David Vlahov; Noya Galai; Joseph Bareta; Steffanie A Strathdee; Kenrad E Nelson; Timothy R Sterling
Journal:  J Infect Dis       Date:  2004-08-17       Impact factor: 5.226

Review 9.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

10.  Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis.

Authors:  Monica Malta; Monica M F Magnanini; Steffanie A Strathdee; Francisco I Bastos
Journal:  AIDS Behav       Date:  2008-11-20
View more
  49 in total

1.  Major depressive disorder during pregnancy and emotional attachment to the fetus.

Authors:  Julie McFarland; Amy L Salisbury; Cynthia L Battle; Katheleen Hawes; Katherine Halloran; Barry M Lester
Journal:  Arch Womens Ment Health       Date:  2011-09-22       Impact factor: 3.633

Review 2.  Neuropsychiatric complications of aging with HIV.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  J Neurovirol       Date:  2012-05-30       Impact factor: 2.643

3.  Cigarette Smoking and Antiretroviral Therapy (ART) Adherence in a Sample of Heavy Drinking HIV-Infected Men Who Have Sex with Men (MSM).

Authors:  Patricia A Cioe; Kristi E Gamarel; David W Pantalone; Peter M Monti; Kenneth H Mayer; Christopher W Kahler
Journal:  AIDS Behav       Date:  2017-07

4.  Development of a personalized bidirectional text messaging tool for HIV adherence assessment and intervention among substance abusers.

Authors:  Karen Ingersoll; Rebecca Dillingham; George Reynolds; Jennifer Hettema; Jason Freeman; Sharzad Hosseinbor; Chris Winstead-Derlega
Journal:  J Subst Abuse Treat       Date:  2013-09-09

Review 5.  Substance use: impact on adherence and HIV medical treatment.

Authors:  Adam Gonzalez; Jennifer Barinas; Conall O'Cleirigh
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

6.  When it comes to lifestyle recommendations, more is sometimes less: a meta-analysis of theoretical assumptions underlying the effectiveness of interventions promoting multiple behavior domain change.

Authors:  Kristina Wilson; Ibrahim Senay; Marta Durantini; Flor Sánchez; Michael Hennessy; Bonnie Spring; Dolores Albarracín
Journal:  Psychol Bull       Date:  2014-12-22       Impact factor: 17.737

7.  Online focus groups as an HIV prevention program for gay, bisexual, and queer adolescent males.

Authors:  Michele L Ybarra; L Zachary DuBois; Jeffrey T Parsons; Tonya L Prescott; Brian Mustanski
Journal:  AIDS Educ Prev       Date:  2014-12

Review 8.  Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.

Authors:  Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell
Journal:  AIDS Behav       Date:  2014-04

9.  Characteristics of intermittent smokers and their association with quit intentions in a sample of heavy-drinking HIV-infected men who have sex with men.

Authors:  Patricia A Cioe; Kristi E Gamarel; David W Pantalone; Peter M Monti; Kenneth H Mayer; Christopher W Kahler
Journal:  AIDS Care       Date:  2016-10-02

10.  Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV.

Authors:  Karen S Ingersoll; Rebecca A Dillingham; Jennifer E Hettema; Mark Conaway; Jason Freeman; George Reynolds; Sharzad Hosseinbor
Journal:  Health Psychol       Date:  2015-12       Impact factor: 4.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.